Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03252704
Other study ID # 16AFHI
Secondary ID
Status Completed
Phase N/A
First received August 14, 2017
Last updated August 16, 2017
Start date March 31, 2016
Est. completion date October 31, 2016

Study information

Verified date August 2017
Source Ingredion Incorporated
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This randomized, double-blind, comparator controlled trial evaluated the blood glucose and insulin responses in healthy adults, after consuming a high fiber or low fiber muffin top.


Description:

The fiber administered in this trial is a resistant starch type 4 derived from high-amylose maize starch. This product is high in dietary fiber (70% total dietary fiber (TDF), AOAC 2009.01 method) and can be used in a variety of bakery applications. The objective of this study was to evaluate the post-prandial blood glucose and insulin responses of healthy adults (n=28) after consuming a muffin top made with resistant starch or control muffin top, in a randomized, double-blind, crossover study. The muffin tops were matched for total weight, total carbohydrate, sugars, protein, and fat. During each 24-hour study period, subjects consumed a standard evening meal, fasted for 12 hours, and arrived at the study clinic the following morning. Serum glucose, serum insulin, and capillary glucose were measured after muffin top consumption. The subjects completed a seven day washout between treatments.


Recruitment information / eligibility

Status Completed
Enrollment 28
Est. completion date October 31, 2016
Est. primary completion date October 31, 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- 18 years of age or older,

- BMI 18.0-29.9 kg/m2,

- fasting glucose = 6.0 mmol/L;

- if female, not of childbearing potential (e.g. taking oral contraceptives, past hysterectomy)

Exclusion Criteria:

- diagnosed metabolic or chronic diseases (e.g. type-2 diabetes);

- cancer diagnosis or treatment within 5 years;

- gastrointestinal problems;

- bowel cleansing during prior week;

- current medications to control blood glucose;

- current medications to control blood cholesterol ;

- current medications to control blood pressure;

- smoker;

- use of medical marijuana;

- alcohol or drug abuse treatment in past 12 months;

- allergy or sensitivity to study products;

- blood donation in prior 2 months;

- if female, currently pregnant, currently breastfeeding, or planning to become pregnant

Study Design


Intervention

Other:
resistant starch (high fiber muffin top)
Muffin top contained 11 g of fiber per portion
control (low fiber muffin top)
Muffin top contained 1 g of fiber per portion

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Ingredion Incorporated KGK Synergize Inc.

Outcome

Type Measure Description Time frame Safety issue
Primary Blood glucose response IV and capillary 0-4 hours after consumption
Secondary Blood insulin response IV 0-4 hours after consumption
Secondary Breath hydrogen response Expired air 0-24 hours after consumption
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04230694 - Continuous Glucose Monitoring of Hospitalized Patients With Diabetes N/A
Active, not recruiting NCT04641689 - Stand Up Kansas: An Intervention to Reduce Sedentary Behavior in the Home Work Environment N/A
Active, not recruiting NCT05056376 - Effectiveness and Cost-Effectiveness of Fully-Automated Digital vs. Human Coach-Based Diabetes Prevention Programs N/A
Completed NCT04547023 - Fasting Versus Fed: Effect of Oral Intake Prior to the Glucose Tolerance Test in Pregnancy N/A
Completed NCT04648397 - The Effect of Chewing Duration on Blood Glucose Levels N/A
Enrolling by invitation NCT04846751 - Exercise Type That Faster Reduces Postprandial Glycemia. N/A
Active, not recruiting NCT04893148 - Efficacy and Safety of iGlarLixi Versus Insulin Glargine Plus Dulaglutide in Patients With Type 2 Diabetes Phase 4
Active, not recruiting NCT01028846 - Central Mechanisms That Regulate Glucose Metabolism in Humans Phase 4
Completed NCT05215210 - The Effect of Long-term Momordica Charantia Supplementation on Blood Glucose Levels N/A
Completed NCT03972878 - Foodprint 1.0: Physiological Acute Responses After Consumption of Confectionary Products N/A
Completed NCT05071950 - The Effect of D-allulose on the Glycemic Changes in Patients With Type 2 Diabetes Mellitus During Ramadan Fasting N/A
Suspended NCT03428295 - Dose Safety Hybrid Closed Loop and Fully Automated Closed Loop Artificial Pancreas Device in CRC Phase 1/Phase 2
Suspended NCT03566511 - Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to Diazoxide Phase 2
Completed NCT04483453 - Effect of Nutritional Intervention on Metabolic Response in Infants N/A
Completed NCT03344185 - The Effect of Glycaemic Index Variation on Blood Glucose and Mood in Healthy Participants Across the Day N/A
Completed NCT03544411 - Effects of Olive Oil and Bran Oil on Antioxidant Levels, Glycemic Control, and Lipid Profile in Patient Type 2 DM Phase 1
Completed NCT05182190 - Effects of Black Bean Pasta Consumption on Biomarkers in Young Adults N/A
Completed NCT04438018 - Towards a Better Understanding of Diabetes Distress, Depression and Poor Glycaemic Control in T2DM
Completed NCT03811132 - Towards a Better Understanding of Diabetes Distress, Depression and Poor Glycaemic Control (DIA-LINK Study)
Completed NCT01818674 - Microclinic Social Network Behavioral Health Trial in Jordan N/A